Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons’ Holdings for Long-Run

Page 1 of 2

The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible for prompting other funds to begin the process of looking into and setting up their own quantitative-based teams to augment their trading, including billionaires Ray Dalio and Steven Cohen. In fact the shift towards automated trading is so strong and the algorithms only continuing to improve, to the point that some in the industry are heralding the future demise of the human trader.


No matter where the investment segment goes from here, Simons will always be one of the best players on the market (as evidenced by his “Quant King” nickname). In 2014, Simons was one of the top-earning hedge fund managers, raking in $1.1 billion, according to Forbes, despite the niggling fact that he retired in 2010 (he does still play a role in the fund). The huge earnings are thanks to the large 5/44 fixed/performance fees RenTech can charge due to its overwhelming success, compared to the industry standard fees of 2/20.

However, despite outstanding performance, these high fees and very strict requirements for becoming a hedge fund investor, make hedge funds inaccessible to individuals with smaller net worths. Nevertheless, hedge funds usually disclose their equity portfolios in their quarterly 13F filings and are obliged to report their changes of ownership once their stake in a company reaches 5% of outstanding stock. Even though this reporting comes with some delays, hedge funds’ filings with the US Securities and Exchange Commission can provide a lot of useful information. Through extensive testing and research, we developed a system in the form of a small-cap strategy, which pools the top 15 small-cap picks among more than 700 funds we track. This strategy performed really well in backtests and it’s been a huge success since we started sharing it in August 2012. Our strategy posted cumulative returns of 132% over the last 2.5 years and outperformed the S&P 500 ETF (SPY) by 79.4 percentage points during that time (see more details here).

Naturally, RenTech is very useful to our strategy, since it has a very diversified equity portfolio and Mr. Simons has a great track record of picking stocks from the small-cap space. However, we won’t be looking at the fund’s small-cap picks in this piece; instead we will take a look at three companies that Renaissance has been holding in its equity portfolio for at least one year. Even though, Renaissance uses quantitative analysis, Mr. Simons also prefers to invest in companies with a long-term growth potential, which is why three largest long-term positions are also among the fund’s largest holdings and have been at the top of the list for at least a year. All three stocks have had a solid performance over the long-run and during the last three years have outperformed their industries by huge margins.

On the first spot is Colgate-Palmolive Company (NYSE:CL), which is also Simons’ top pick, as of the end of last year. Colgate-Palmolive Company (NYSE:CL) has been among Simons’ top 10 holdings since the middle of 2012, though the position became the largest in terms of value only during the fourth quarter, after it was raised by 15% to 12.58 million shares valued at $870.09 million. That makes him by far the largest shareholder among the funds from our database, followed by Jean-Marie Eveillard’s First Eagle Asset Management, which holds 4.83 million shares. The consumer products company, which is most well-known for its line of oral hygiene products, has had its shares rise by 32% since the middle of 2012. The $62.39 billion market-cap company recently surpassed Ford Motor Company (NYSE:F) as the 74th most valuable company in the world, according to The Online Investor.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!